Besides, preclinical studies have shown that high NEK2 levels can induce tumorigenesis by mediating chromosome instability and aneuploidy, while its downregulation can lead to cancer cells death [42], suggesting a role for NEK2 as a potential target to treat cancer. This evidence concerns the gene NEK2 and cancer.